BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 36290917)

  • 1. Fluorescence Signal-Readout of CRISPR/Cas Biosensors for Nucleic Acid Detection.
    Huang Z; Liu S; Pei X; Li S; He Y; Tong Y; Liu G
    Biosensors (Basel); 2022 Sep; 12(10):. PubMed ID: 36290917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gold Nanomaterials-Implemented CRISPR-Cas Systems for Biosensing.
    Fu R; Xianyu Y
    Small; 2023 May; 19(21):e2300057. PubMed ID: 36840654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal amplification and output of CRISPR/Cas-based biosensing systems: A review.
    Wang SY; Du YC; Wang DX; Ma JY; Tang AN; Kong DM
    Anal Chim Acta; 2021 Nov; 1185():338882. PubMed ID: 34711321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-canonical CRISPR/Cas12a-based technology: A novel horizon for biosensing in nucleic acid detection.
    Lei X; Cao S; Liu T; Wu Y; Yu S
    Talanta; 2024 May; 271():125663. PubMed ID: 38232570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas Systems towards Next-Generation Biosensing.
    Li Y; Li S; Wang J; Liu G
    Trends Biotechnol; 2019 Jul; 37(7):730-743. PubMed ID: 30654914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleic Acid Detection Using CRISPR/Cas Biosensing Technologies.
    Aman R; Mahas A; Mahfouz M
    ACS Synth Biol; 2020 Jun; 9(6):1226-1233. PubMed ID: 32159950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas-based nucleic acid detection strategies: Trends and challenges.
    Zhou J; Li Z; Seun Olajide J; Wang G
    Heliyon; 2024 Feb; 10(4):e26179. PubMed ID: 38390187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of a fluorescence/colorimetric biosensor based on the cleavage activity of CRISPR-Cas12a for the detection of non-nucleic acid targets.
    Wang Y; Peng Y; Li S; Han D; Ren S; Qin K; Zhou H; Han T; Gao Z
    J Hazard Mater; 2023 May; 449():131044. PubMed ID: 36821893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of CRISPR-Mediated Nucleic Acid Detection Technologies and Their Applications in the Livestock Industry.
    Zhang X
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches.
    Ahmed MZ; Badani P; Reddy R; Mishra G
    J Mol Diagn; 2021 Nov; 23(11):1433-1442. PubMed ID: 34454111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplexed Detection Strategies for Biosensors Based on the CRISPR-Cas System.
    Wei C; Lei X; Yu S
    ACS Synth Biol; 2024 Jun; 13(6):1633-1646. PubMed ID: 38860462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive Small Molecule Aptasensing based on Hybridization Chain Reaction and CRISPR/Cas12a Using a Portable 3D-Printed Visualizer.
    Ma L; Liao D; Zhao Z; Kou J; Guo H; Xiong X; Man S
    ACS Sens; 2023 Mar; 8(3):1076-1084. PubMed ID: 36651835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas based virus detection: Recent advances and perspectives.
    Yin L; Man S; Ye S; Liu G; Ma L
    Biosens Bioelectron; 2021 Dec; 193():113541. PubMed ID: 34418634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas systems for the detection of nucleic acid and non-nucleic acid targets.
    Su W; Li J; Ji C; Chen C; Wang Y; Dai H; Li F; Liu P
    Nano Res; 2023 Mar; ():1-14. PubMed ID: 37359078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ultrasensitive and specific point-of-care CRISPR/Cas12 based lateral flow biosensor for the rapid detection of nucleic acids.
    Mukama O; Wu J; Li Z; Liang Q; Yi Z; Lu X; Liu Y; Liu Y; Hussain M; Makafe GG; Liu J; Xu N; Zeng L
    Biosens Bioelectron; 2020 Jul; 159():112143. PubMed ID: 32364943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergetic performance of isothermal amplification techniques and lateral flow approach for nucleic acid diagnostics.
    Mukama O; Nie C; Habimana JD; Meng X; Ting Y; Songwe F; Al Farga A; Mugisha S; Rwibasira P; Zhang Y; Zeng L
    Anal Biochem; 2020 Jul; 600():113762. PubMed ID: 32387190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Framework-Hotspot Enhanced Trans Cleavage of CRISPR-Cas12a for Clinical Samples Detection.
    Li F; Li J; Yang W; Yang S; Chen C; Du L; Mei J; Tang Q; Chen X; Yao C; Yang D; Zuo X; Liu P
    Angew Chem Int Ed Engl; 2023 Aug; 62(32):e202305536. PubMed ID: 37278518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas12a Powered DNA Framework-Supported Electrochemical Biosensing Platform for Ultrasensitive Nucleic Acid Analysis.
    Su J; Ke Y; Maboyi N; Zhi X; Yan S; Li F; Zhao B; Jia X; Song S; Ding X
    Small Methods; 2021 Dec; 5(12):e2100935. PubMed ID: 34928030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas-based techniques for pathogen detection: Retrospect, recent advances, and future perspectives.
    Huang T; Zhang R; Li J
    J Adv Res; 2023 Aug; 50():69-82. PubMed ID: 36367481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA reporter based CRISPR/Cas12a biosensing platform for sensitive detection of circulating tumor DNA.
    Deng F; Li Y; Sang R; Zhang C; Hall T; Yang D; Goldys E
    Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38083573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.